Heparin-Coated Stent-Graft under the microscope: new analysis of nearly 1,000 patients
NCT ID NCT05459818
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study combines data from nearly 1,000 patients who received a special stent-graft (the GORE VIABAHN with a heparin coating) for peripheral artery disease in the leg. Researchers want to see how well the device keeps arteries open over time and which patient factors affect success. The goal is to better understand who benefits most from this treatment.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
GORE® VIABAHN® endoprosthesis with heparin bioactive surface (a stent-graft device)
What this could lead to
If successful, this analysis could help doctors identify which patients with peripheral artery disease are most likely to benefit from this device, leading to better treatment decisions.
What could go wrong
This is a meta-analysis of existing studies, not a new trial. It cannot prove the device works better than other treatments, and results depend on the quality of the original studies.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PERIPHERAL ARTERIAL DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Rijnstate
Arnhem, Netherlands